(Q36024842)

11 August 2017

1 reference

title

Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma (English)

1 reference

11 August 2017

1 reference

T. Coyle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568176

9 October 2022

P. Bushunow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568176

9 October 2022

J. Winfield

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568176

9 October 2022

J. Wright

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568176

9 October 2022

S. Graziano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568176

9 October 2022

language of work or name

English

0 references

publication date

1 May 1992

1 reference

11 August 2017

15 May 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1568176

9 October 2022

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

11 August 2017

volume

69

1 reference

11 August 2017

issue

10

1 reference

11 August 2017

page(s)

2532-2540

1 reference

MOPP regimen as primary chemotherapy for brain tumors in infants.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Salvage chemotherapy for recurrent primary brain tumors in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Combination chemotherapy with MOPP in children with recurrent brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Hypersensitivity to procarbazine (Matulane®) manifested by fever and pleuropulmonary reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Pulmonary toxicity following MOPP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Cytotoxic drug-induced fever: a report on procarbazine-induced hyperpyrexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Anticonvulsant drugs. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

ChlVPP combination chemotherapy for Hodgkin's disease: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Chemotherapy of nonirradiated malignant gliomas.Phase II: Study of the combination of methyl-CCNU, vincristine, and procarbazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762)(MOPP vs OPP) in children with recurrent brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Combined intraarterial and systemic chemotherapy for intracerebral tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Successful chemotherapy for recurrent malignant oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Acute toxicity from BOPP (BCNU, vincristine, procarbazine, cisplatinum) chemotherapy for glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Combination chemotherapy in oat cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Cyclophosphamide, vincristine and procarbazine in the treatment of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Comparison of low dose radiation therapy alone or combined with procarbazine (NSC-77213) for unresectable epidermoid carcinoma of the lung, stage t3, N1, N2, or ML

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

Hepatotoxicity of Cytostatic Drugs Evaluated by Liver Function Tests and Appearance of Jaundice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819920515%2969%3A10%3C2532%3A%3AAID-CNCR2820691024%3E3.0.CO%3B2-I

10.1002/1097-0142(19920515)69:10<2532::AID-CNCR2820691024>3.0.CO;2-I

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference